MultiValent Biotherapies, Inc.
Biotechnology company · Los Altos, California, United States
MultiValent Biotherapies, Inc. is a biotechnology company headquartered in Los Altos, California, United States. Its earliest recorded incorporation is in 2025. It has reported private securities offerings to the US SEC, most recently $10 million sold in a notice filed in 2026.
MultiValent Biotherapies at a glance
What does MultiValent Biotherapies do?
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $10 million sold (2026).
Frequently asked questions about MultiValent Biotherapies
Where is MultiValent Biotherapies headquartered?
MultiValent Biotherapies, Inc. is headquartered in Los Altos, California, United States.
What does MultiValent Biotherapies do?
MultiValent Biotherapies, Inc. is a biotechnology company.
When was MultiValent Biotherapies founded?
The earliest incorporation on record for MultiValent Biotherapies, Inc. is in 2025, according to public company registers.
Similar companies
- Quadriga Biosciences, IncLos Altos, California, United States
- Sociometrics CorporationLos Altos, California, United States
- Cardiac RSK3 Inhibitors, LLCLos Altos, California, United States
- Sciogen LLCLos Altos, California, United States
- Maxymune Therapeutics, Inc.Los Altos, California, United States
- Retrotope, Inc.Los Altos, California, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences